Differentiated thyroid cancer in childhood is rare. Apart from family history, radiation exposure is a major risk factor. Although its clinical course is quite aggressive with higher rates of lymph node and pulmonary metastases as compared to adults, the final outcome tends to be favorable with mortality rates less than 2%. We herein review the clinical picture, genetic background response to treatment and recurrence rates of differentiated thyroid cancer in children and young adolescents are thoroughly reviewed and the main differences with adult differentiated thyroid cancer are highlighted.
6,7 and follicular for 1, [5] [6] [7] [8] Dominant histologic variants of papillary thyroid cancer in childhood are solid, follicular and diffuse EPIDEMIOLOGY Differentiated thyroid cancer is quite rare in childof 10 years and reaches a zenith in adolescence when 1 Specifically, the incidence 2, 3 Prepubertally the rates are equal between males and females, whereas in adolescence there is a female predominence with a female to male ratio between common malignancy in adolescent girls 3-5 ( Figure   Figure 1 . Incidence of thyroid cancer in childhood and adoles- 9 The incidence of NIFTP has not yet been widely investigated, although a recent study reported 10 Medullary, poorly differentiated and anaplastic thyroid
RISK FACTORS
history of papillary thyroid carcinoma, comprising cases of adenomatous polyposis, DICER 1, PTEN hamartoma tumor syndrome, Carney complex or 11 However the main risk factor for PTC is radiation exposure 12, 13 for children <5 14, 15 In particular, approximately 5 years after the 1986 Chernobyl Nuclear Power Plant accident the incidence of papillary thyroid cancer in the con--sian Federation increased from less than 1 case per million per year before the accident to more than 90 cases per million per year and the exposed children 16 After 1996, the incidence declined progressively and -sure to radiation, were reported in pediatric patients 5, [17] [18] [19] A non-significant increase in the prevalence of thyroid cancer was reported after the Fukushima Daiichi Nuclear Power Plant disaster where the radiation exposure was one tenth or less
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MUTATIONAL STATUS
As shown in Table 1 , a major difference between adult and pediatric PTC is that in children RET/PTC in childhood), while activating point mutations in the signal transducing pathway, such as RAS (NRAS being the most frequent) and BRAF mutations, account for 20 PET/PTC rearrangements occur after radiation exposure or internal contamination, this be-21 As radiation exposure induces DNA double-strand breaks, the RET gene and associated partners are highly vulnerable for recombination since they are juxtaposed in the nuclei 21, 22 The overall prevalence of RET/PTC diverges between sporadic 23,24 with RET/PTC3 being associated with more aggressive tumors and RET/PTC1 24, 25 Due to interindividual variations in response to radiation, the role of genetic factors such as single nucleotide polymorphisms (SNPs) in the ATM and FOXE1 genes in radiation-induced PTC has been documented, suggesting that its etiology may involve a DNA repair pathway, a thyroid morphogenesis pathway and/or dysregulation of the 26 In contrast to BRAF mutations, these RET/PTC rearrangements do not lead to genomic instability and dedifferentiation, which explains their better response to RAI and lower 7, 27 Several studies have demonstrated that sodium iodine symporter expression is greater than in 28, 29 Moreover, a subsequent study showed that the expression of PDS, TPO and TSHR mRNA was higher in children compared to adults (22-59 years)
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CLINICAL PRESENTATION
Thyroid cancer in children usually presents as a 31, 32 The incidence of clinically palpable thyroid nodules in children is estimated to be around 33 Nodules in children carry a greater risk of malignancy compared [34] [35] [36] It is noteworthy that even autonomously functioning hot nodules carry a higher risk of malig- 
FOLLOW-UP STRATEGIES
Follow-up is accomplished by clinical examination, measurement of serum Tg levels, neck ultrasonography sensitive marker for residual or recurrent disease and should be measured along with TgAb since the pres- [74] [75] [76] The magnitude of TSH-stimulated Tg elevation in the absence of TgAb distinguishes between patients in there is a high probability of long-term remission and the patient is mainly monitored by TSH-suppressed Tg levels, TSH is maintained in the low-normal range 40 A low-level TSH-stimulated Tg <10ng/ml indicates persistent disease requiring serial TSH-supressed measurements and radiological imaging, although this value may 77 A clearly elevated TSH-stimulated Tg >10ng/ml indicates structural disease necessitating localization and 40 Cervical ultrasonography should be performed 6 months postoperatively, then annually for 5 years and thereafter for low-risk patients individu- 
